Author

David A. Guel

Observed names: D A Guel, D Aaron Guel, D. A. Guel, D. Aaron Guel, David A Guel, David Guel

Institution: Allegheny General Hospital

Observed institutions: Allegheny Health Network, Washington University in St. Louis, Allegheny General Hospital, Research to Prevent Blindness, Valley Retina Institute, The University of Texas Southwestern Medical Center

OpenAlex ID: A5037073552

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy

2009 · V H Gonzalez, G P Giuliari, et al. · British Journal of Ophthalmology · 65

Long Term Assessment of Confluent Laser Photocoagulation for the Treatment of Retinopathy of Prematurity

2007 · Rodolfo M. Banda, Victor H. González, et al. · Investigative Ophthalmology & Visual Science · 22

The Role of Atopy in Corneal Graft Survival in Keratoconus

2011 · Jacob K Thomas, D Aaron Guel, et al. · Cornea · 19

Pegaptanib Sodium for the Treatment of Proliferative Diabetic Retinopathy and Diabetic Macular Edema

2009 · Gian Giuliari, David Guel, et al. · Current Diabetes Reviews · 12

Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary

2010 · Gian Paolo Giuliari, D. Aaron Guel, et al. · Canadian Journal of Ophthalmology · 9

Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development

2018 · Ashten N. Omstead, Juliann E. Kosovec, et al. · Cancer Investigation · 5

Is there a role for upfront surgery in patients with N2 disease and good prognostic features?

2019 · Candice Lee, David A. Guel, et al. · Journal of Thoracic Disease · 3

Use of Pegaptanib Sodium (Macugen®) for the Regression of Proliferative Diabetic Retinopathy

2006 · Víctor H. González, Vincent R. Vann, et al. · Investigative Ophthalmology & Visual Science · 3

Pegaptanib Sodium (Macugen®) versus Panretinal Photocoagulation (PRP) for the Regression of Proliferative Diabetic Retinopathy

2007 · Víctor H. González, Vincent R. Vann, et al. · Investigative Ophthalmology & Visual Science · 2

Commentary: The search for the Holy Grail to prevent anastomotic leaks: Let's keep looking, it is not omentoplasty

2019 · D. Aaron Guel, Benny Weksler · Journal of Thoracic and Cardiovascular Surgery · 1

Pegaptanib Sodium (Macugen) as an Adjunct in Proliferative Diabetic Retinopathy Refractory to Laser Treatment

2008 · Yeliana M. Valencia Gómez, Gian Paolo Giuliari, et al. · Investigative Ophthalmology & Visual Science · 1

Pegaptanib Sodium (Macugen®) as an Adjunct in the Management of Refractory Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema

2007 · Yingying Su, Víctor H. González, et al. · Investigative Ophthalmology & Visual Science · 1

Safety and Efficacy of Combining Macugen and PDT in Patients with Age–related Macular Degeneration

2006 · Vincent R. Vann, Rodolfo M. Banda, et al. · Investigative Ophthalmology & Visual Science · 1

Serial Endoscopic Evaluation of Esophageal Disease in A Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development

2017 · Ashten N. Omstead, David A. Guel, et al. · Gastroenterology

Abstract P249: Determinants of Descending Aortic Dimensions in a Multi-Ethnic Population: The Dallas Heart Study

2012 · David A Guel, Matthias Peltz, et al. · Circulation

Vascular Remodeling After Intravitreal Pegaptanib in Ischemic Diabetic Retinopathy

2008 · Gian Paolo Giuliari, Y. M. Morilla, et al. · Investigative Ophthalmology & Visual Science

Works count: 16

Citation count: 144

H-index: 5

I10-index: 4